Shockwave Medical concludes enrollment in all-female coronary IVL study Ruchika Sharma2 Nov 2024 2:16 PM ISTSanta Clara: Shockwave Medical, Inc., part of Johnson & Johnson MedTech has announced the completion of enrollment in EMPOWER CAD, the first...
JnJ completes acquisition of V Wave Ruchika Sharma10 Oct 2024 12:34 PM ISTNew Brunswick: Johnson & Johnson has announced that it has successfully completed the acquisition of V-Wave Ltd., a privately-held company...
JnJ to discontinue Phase 2 Field Study evaluating investigational antiviral for Dengue prevention Ruchika Sharma8 Oct 2024 4:50 PM ISTRaritan: Johnson & Johnson has announced it is discontinuing the Phase 2 field study (NCT05201794) evaluating the efficacy of investigational...
JnJ seeks USFDA nod for Darzalex Faspro-based quadruplet regimen for newly diagnosed multiple myeloma patients for whom transplant is not planned Ruchika Sharma6 Oct 2024 10:30 AM ISTRaritan: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
NCDRC orders JnJ to pay Rs 35 lakh compensation for faulty hip replacement device Yakshi Chugh3 Oct 2024 6:07 PM ISTIn a significant ruling, the National Consumer Disputes Redressal Commission (NCDRC) has ordered Johnson & Johnson Limited to compensate a...
Apex Consumer Court slaps Rs 35 lakh compensation on Johnson & Johnson for faulty hip replacement device Ruchika Sharma1 Oct 2024 12:35 PM ISTNew Delhi: In a significant ruling, the National Consumer Disputes Redressal Commission (NCDRC) has ordered Johnson & Johnson Limited to...
Darzalex-based quadruplet regimen receives positive CHMP opinion for transplant-eligible patients with newly diagnosed multiple myeloma Ruchika Sharma22 Sept 2024 12:30 PM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...
JnJ gets USFDA nod for Rybrevant plus standard of care chemotherapy for lung cancer treatment Ruchika Sharma21 Sept 2024 4:00 PM ISTRaritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT (amivantamab-vmjw) in...
JnJ seeks approval of nipocalimab to treat generalized myasthenia gravis Ruchika Sharma2 Sept 2024 4:29 PM ISTSpring House: Johnson & Johnson has announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug...
European Commission approves Janssen-Cilag Balversa for adult patients with metastatic urothelial carcinoma Ruchika Sharma25 Aug 2024 10:00 AM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the European Commission (EC) has approved...
JnJ chemotherapy free lung cancer treatment Rybrevant plus Lazcluze gets USFDA okay Ruchika Sharma21 Aug 2024 12:30 PM ISTNew Jersey: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT (amivantamab-vmjw) plus...
Johnson & Johnson to acquire V-Wave Ruchika Sharma21 Aug 2024 10:00 AM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately-held...
